“Lipid Profile in People Starting Antiretroviral Therapy With Efavirenz or Dolutegravir Based Regimens from a Reference Center in Brazil: A Cohort Study”. Research, Society and Development 11, no. 5 (April 15, 2022): e55811528662. Accessed December 5, 2025. https://rsdjournal.org/rsd/article/view/28662.